Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) Shares Outstanding (Weighted Average): 2015-2025

Historic Shares Outstanding (Weighted Average) for Aytu Biopharma (AYTU) over the last 11 years, with Jun 2025 value amounting to $6.2 million.

  • Aytu Biopharma's Shares Outstanding (Weighted Average) rose 61.20% to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 million, marking a year-over-year increase of 61.20%. This contributed to the annual value of $6.2 million for FY2025, which is 10.81% up from last year.
  • Per Aytu Biopharma's latest filing, its Shares Outstanding (Weighted Average) stood at $6.2 million for FY2025, which was up 10.81% from $5.6 million recorded in FY2024.
  • Aytu Biopharma's 5-year Shares Outstanding (Weighted Average) high stood at $6.2 million for FY2025, and its period low was $1.3 million during FY2021.
  • In the last 3 years, Aytu Biopharma's Shares Outstanding (Weighted Average) had a median value of $5.6 million in 2024 and averaged $5.2 million.
  • Data for Aytu Biopharma's Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 109.30% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Aytu Biopharma's Shares Outstanding (Weighted Average) stood at $1.3 million in 2021, then soared by 53.25% to $1.9 million in 2022, then soared by 95.99% to $3.8 million in 2023, then spiked by 47.30% to $5.6 million in 2024, then grew by 10.81% to $6.2 million in 2025.